
This position statement, updated from the 2015 guidelines, provides recommendations for managing chronic suppurative lung disease (CSLD) and bronchiectasis in Australian and New Zealand children/adolescents and adults. Recommendations include early diagnosis, baseline investigations, individualized management plans, intensive treatment, airway clearance techniques, exacerbation management, Pseudomonas aeruginosa eradication, long-term therapy, and ongoing monitoring for complications and co-morbidities. The statement emphasizes the need for coordinated care between healthcare providers and optimal care for under-served populations.
Like
Save
Share